Nordisk Novolin 70/30 10ml

What is NORD70 Nordisk Novolin 70/30 10ml?

NORD70 Nordisk Novolin 70/30 10ml is a premixed human insulin formulation containing 70% insulin NPH (intermediate-acting) and 30% insulin regular (short-acting). Manufactured by Novo Nordisk, it helps control blood glucose levels in people with type 1 or type 2 diabetes. This 10ml vial provides multiple doses and is designed for subcutaneous injection, typically taken before meals to manage both mealtime and background insulin needs.

Key features

• Premixed formula — Combines 70% NPH and 30% regular insulin for dual-action glucose control.
• 10ml vial — Offers multiple doses for extended use.
• Human insulin — Biologically identical to natural insulin.
• Intermediate and short-acting — Covers both basal and bolus insulin requirements.
• Manufactured by Novo Nordisk — Trusted global insulin producer.
• Requires refrigeration — Must be kept cool before use to maintain potency.
• Next Business Day shipping recommended — Ensures temperature-sensitive delivery.

Who is NORD70 Nordisk Novolin 70/30 10ml for?

This insulin is intended for individuals with type 1 or type 2 diabetes who require both basal and mealtime insulin coverage. It's especially useful for patients who prefer fewer injections and have consistent daily routines. However, it may not suit those needing flexible dosing adjustments, as the fixed ratio limits customization compared to using separate insulins.

How does NORD70 Nordisk Novolin 70/30 10ml compare?

Compared to single-component insulins, NORD70 offers convenience but less dosing flexibility. It's similar to other premixed insulins like 70/30 formulations from different brands but differs from modern analogs like insulin lispro mix, which have faster onsets. Unlike long-acting insulins, it requires multiple daily injections and acts more quickly. It's a cost-effective option compared to newer insulin analogs but requires careful timing with meals.